university of nebraska

university of nebraska

Ibrutinib, Bendamustine, and Rituximab in Previously Treated CLL/SLL

2d ago
SOURCE  

Description

Asher Alban Akmal Chanan-Khan, MD of the Mayo Clinic Cancer Center and James O. Armitage, MD, of University of Nebraska Medical Center discuss an important treatment option that significantly improved overall response rate and reduced risk of progression or death by 80%. (LBA7005)